Review decision – May 2017
Decision to move the existing guidance to the static list
We were proposing that the guidance should be transferred to the ‘static guidance list’ with a post publication update to reflect the publication of the updated NICE guideline on suspected cancer.
During consultation, the majority of comments received from stakeholders agreed with the proposal put forward. After consideration of all of the comments, the NICE Guidance Executive has approved this decision. We have also included a table that lists any changes made to the names of faecal calprotectin tests included in DG11 since its publication.
This page was last updated: